Neuphoria Therapeutics Inc (NEUP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 663 | 0 | 0 | 0 | 0 |
| Gross Profit | 663 | N/A | N/A | N/A | N/A |
| Operating Expenses | 4,366 | 3,568 | 5,478 | 2,394 | 0 |
| Operating Income | -3,704 | -3,568 | -5,478 | -2,394 | N/A |
| Other Income | 1,772 | 2,631 | 2,757 | -368 | 0 |
| Pre-tax Income | -1,932 | -937 | -2,721 | -2,762 | 0 |
| Income Tax | 12 | -132 | -34 | 16 | N/A |
| Net Income Continuous | -1,943 | -805 | -2,687 | -2,778 | N/A |
| Net Income | $-1,943 | $-805 | $-2,687 | $-2,778 | $N/A |
| EPS Basic Total Ops | -1.23 | -0.62 | -10.48 | -2.83 | N/A |
| EPS Basic Continuous Ops | -1.23 | -0.62 | -2.57 | -2.83 | N/A |
| EPS Diluted Total Ops | -1.79 | -0.62 | -10.48 | -2.83 | N/A |
| EPS Diluted Continuous Ops | -1.23 | -0.62 | -2.57 | -2.83 | N/A |
| EPS Diluted Before Non-Recurring Items | -1.23 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-3,537 | $-3,402 | $-5,312 | $-2,228 | $N/A |